| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


From the Department of Pathology,* University of Southern California Keck School of Medicine, Los Angeles; and the Department of Biological Sciences,
Program in Molecular and Computational Biology, University of Southern California, Los Angeles, California
| Abstract |
|---|
|
|
|---|
This nonrandom MCR mutation pattern is consistent with selection,2,5-8
which may occur during tumor progression. However, selection is also possible in normal colon because each crypt contains multiple stem cells that compete for survival within a niche.9-15
Random stem cell loss with replacement occurs in every crypt9,10
and eventually results in niche succession or a "bottleneck" whenever all except one stem cell lineage becomes extinct (see Figure 1
in Calabrese et al16
). Niche succession resembles the clonal evolution of tumor progression17
but occurs during pretumor progression16
without a change in visible phenotype. Normally a random stem cell drifts to dominance because mutations are rare in normal colon. However, a dominant stem cell could be selected by mutations that confer survival advantages over other stem cells.
|
Despite a potential to alter stem cell survival, heterozygous APC mutations appear inert (see Figure 1A
) because FAP and non-FAP crypts are morphologically identical,21,22
although crypt fission is more frequent in FAP.23
The first APC mutation may predispose to tumorigenesis simply because biallelic APC mutations are necessary for neoplasia.1
However, stem cells cannot be visualized, and normal or abnormal survival is usually inferred in model systems that artificially create heterogeneous appearing crypts.11-15
Such experimental approaches are impractical in human colons, but recent studies9
illustrate that colon stem cell niche dynamics can be inferred from crypt methylation patterns that arise during aging. An analysis of FAP crypt sequences may potentially detect altered stem cell survival because the diversity of a population reflects the time since a last bottleneck. Older populations have longer-lived lineages and therefore are more genetically diverse. If heterozygous APC mutations enhance stem cell survival, FAP niche succession should occur less frequently and crypt methylation patterns should be more diverse. Here we compare methylation patterns between FAP and non-FAP colons and infer that stem cell clonal evolution is slower and stem cell survival is enhanced in some normal appearing FAP colons.
| Materials and Methods |
|---|
|
|
|---|
Fresh colons were obtained from five FAP, one AFAP, and six non-FAP patients (Table 1)
. These colons have not been previously reported except for the non-FAP patient L, which was previously used to characterize normal niches.9
All FAP colons had more than 100 polyps. Patient D had a previous partial colectomy at age 21 because of polyposis.
|
Crypt Isolation
Crypts were isolated from
1 to 2 cm2 polyp-free patches of fresh colons with an ethylenediaminetetraacetic acid solution as previously described.7
DNA was isolated from individual crypts in 10-µl volumes (100 mmol/L Tris-HCl, 4 mmol/L ethylenediaminetetraacetic acid, pH 8.0, with 200 µg/ml Proteinase K) for 4 hours at 56°C. After boiling for 5 minutes the DNA was bisulfite converted using an agarose bead method.24
Methylation Analysis
Bisulfite-treated DNA from individual crypts was amplified with primers for a CpG island present in the CSX gene (also called MINT2325 ) as previously described.9 After 42 polymerase chain reaction cycles, products were cloned (TOPO TA cloning kit; Invitrogen, Carlsbad, CA), and sequences from eight individual clones were analyzed from each crypt. All Cs not 5' to Gs were converted to Ts, consistent with complete bisulfite conversion.
Methylation patterns are defined as the 5' to 3' order of methylation at CpG sites and each polymerase chain reaction product or tag can be summarized with a binary code (0 is unmethylated and 1 is methylated). The CSX polymerase chain reaction product has eight CpG sites and therefore 256 combinations or unique tags are possible. The multiple tags sequenced from each crypt can be described by two relevant measurements.9 A measurement of crypt diversity is the number of unique tags per crypt. This value may range from one to eight because eight tags are sampled from each crypt. Average methylation is defined as the average number of CpG sites methylated in a tag or crypt.
Crypt Niche Simulations
Stem cell niches were simulated as previously described.9
This model starts at birth with unmethylated CpG islands and predicts how percent methylation and numbers of unique tags per crypt (crypt diversity) increase with age. Parameters (Figure 1B)
and their values for a baseline non-FAP niche scenario are numbers of stem cells (n = 64), probabilities of a stem cell division asymmetrically producing one differentiated and one stem cell daughter (p1 = 0.95), or symmetrically two differentiated or two stem cell daughters (p0, p2, with p0 = p2 = 0.025), methylation error rates (2 x 10-5 per division per CpG site, with both methylation and demethylation possible), and stem cell division rates (once per day). At least 1000 simulations were performed for each scenario.
| Results |
|---|
|
|
|---|
|
|
Individual crypt values may vary because of stochastic methylation errors and stem cell turnover. Therefore, to determine whether measured crypt values are consistent or inconsistent with various crypt model parameters, simulations were performed based on the ages and numbers of crypts sampled from each colon. These simulations produce varying outcomes, and intervals that include 95% of their outcomes were plotted on Figure 4
. Average numbers of unique tags per crypt measured from the AFAP and the six non-FAP colons were consistent with the baseline crypt scenario (Figure 4)
. Only one FAP colon (patient E) was consistent with the baseline crypt scenario (Figure 4)
.
|
3.2 average unique tags per crypt was observed even when rates were increased to three divisions per day (Figure 5A)
|
Clonal evolution is slower with enhanced stem cell survival because intervals between bottlenecks are increased. Calculated median times for niche succession were
8.2 years (95% intervals of 2.7 to 19.2 years) for non-FAP crypts versus
30 years (95% intervals of 10 to 81 years) for FAP crypts (Figure 1
; B to D). The net effect is an increase in crypt diversity without an increase in error or mitotic rates.
Stem cell survival appeared dependent on mutation location, with enhanced survival associated with mutations that remove some but not all catenin-binding repeats (Table 1)
. The FAP colon with normal stem cell niche dynamics (patient E) had a truncating mutation near the N-terminus (codon 213), and its mutant protein would lack armadillo- and catenin-binding repeats. The AFAP patient had a distal 3' mutation at codon 2564 that would retain all catenin repeats. Mutations associated with increased stem cell survival retained at least one catenin-binding motif. Mutations in patients A and B were within the MCR (codons 1462 and 1356) and remove some 20-amino acid catenin repeats. The mutation in patient C was within the 15-amino acid repeat region (codon 1061) and would delete the 20-amino acid catenin repeat region.
To determine how changes in stem cell survival may influence progression, we consider an independent data set from Ashley26
that provides ages at cancer for FAP patients. Compared to sporadic cancers, FAP cancers may require one less somatic oncogenic mutation because an APC mutation is inherited. However, others26,27
have found that in log-log plots of cancer incidence versus age, the slope for FAP patients decreases by more than one from the slope for the general colon cancer population. FAP cancers therefore appear earlier than expected if germline APC mutations simply reduced the total number of oncogenic mutations by one compared to sporadic cancers. For our pretumor progression model, when we compare the predicted cumulative cancer frequency with parameters inferred from the SEER data set16
to the FAP data set there is little agreement (Figure 6)
. However, when we reduce the number of mutations from five to four, but keep the other parameters the same, the models prediction is similar to the clinical FAP data (Figure 6)
. Further, when we also increase the number of stem cells per crypt consistent with the simulation described above, the model agrees even more with the FAP data (Figure 6)
. These calculations indicate that enhanced stem cell survival facilitates progression to cancer, and also illustrate how our pretumor progression model can link stem cell survival with cancer epidemiology.
|
| Discussion |
|---|
|
|
|---|
Recent studies illustrate colon crypt stem cell survival can be reconstructed using methylation patterns as cell fate markers.9 Human colon crypts are maintained by multiple stem cells that reside in niches. Methylation patterns are faithfully copied from generation to generation, but sometimes errors occur. Some errors will be propagated but most stem cells and their errors are lost during normal niche turnover.16 Therefore, crypt methylation patterns reflect a balance between stochastic error loss and error creation. The higher methylation pattern diversity observed in some FAP colons is consistent with enhanced stem cell survival and slower niche stem cell clonal evolution.
Heterozygous APC Mutations Enhanced Stem Cell Survival
Niches are defined by inductive interactions between stem cells and surrounding mesenchyme.14,15 Stem cell extinction results from a physical loss of inductive interactions by both daughter cells whereas clonal expansion is the retention of both daughter cells within the niche. Stem cell loss with replacement normally results in the random extinction of all niche stem cell lineages except one.16 However, a dominant stem cell may also be selected if it acquires a mutation that increases its ability to remain within a niche.
WNT signaling pathways influence stem cell niche survival in Drosophila gonads,19 hair follicles,30 and murine intestinal crypts.31 APC has a regulatory role in WNT pathways, binding to ß-catenin and marking it for degradation.2 Although APC protein levels appear greatest at crypt lumens,32 low expression in stem cells and their daughters may help determine their fates. In the absence of APC, ß-catenin enters the nucleus and with TCF factors activates transcription. TCF4/ß-catenin-mediated transcription is essential for crypt stem cell survival because Tcf4-deficient mice lack stem cells.31 Up-regulation of ß-catenin/TCF4 transcription by dominant-negative APC mutations has been observed in vitro,33 allowing for altered WNT signaling in normal FAP crypts. ß-Catenin also interacts with cadherins to modulate cell adhesion. Elevated ß-catenin levels in APC-deficient cells result in a somewhat paradoxical increase in cell adhesion,34,35 which may favor niche stem cell retention.
Heterozygous APC mutations affecting stem cell survival appear to follow the same general pattern as polyposis,2 but germline mutations outside the MCR still conferred enhanced stem cell survival. How heterozygous APC mutations affect stem cell survival is uncertain, but enhanced survival was associated with mutations (codons 1061, 1356, and 1462) that remove some but not all catenin-binding repeats. The FAP patient without enhanced stem cell survival had a proximal truncating mutation (codon 213) that removed all catenin-binding repeats. A 3' AFAP mutation (codon 2564) would retain all catenin repeats and also did not exhibit evidence of enhanced stem cell survival.
The absolute number of stem cells per human colon crypt is unknown. A niche size of 64 was chosen for a baseline non-FAP crypt model9
because its parameters follow the scale of smaller (400 versus 2000 cells per colon crypt) but better characterized murine crypts in which 5% of stem cell divisions are thought to be symmetrical.12
Regardless of absolute niche size, the current data are consistent with enhanced stem cell survival in some FAP crypts, although our analysis cannot distinguish between reduced stem cell loss (Figure 1C)
, increased numbers of stem cells (Figure 1D)
, or some combination of these changes. Heterozygous APC mutations may increase epithelial cell sensitivity to niche WNT signals, effectively increasing niche size and stem cell number. Heterozygous APC mutations may also increase stem cell adhesion to surrounding niche mesenchyme, resulting in decreased stem cell extinction.
Consistent with morphological similarities between normal FAP and non-FAP crypts,21,22
the enhanced stem cell survival inferred by our analysis would be occult (Figure 1)
. Crypt morphology, cell numbers, division, migration, and death rates would be unchanged. For example, with or without decreased extinction, every day 64 stem cells divide and 64 stem cell daughters leave the niche and differentiate. The only change is how niche positions are inherited among visually identical stem cell daughters. In the absence of stem cell markers, niche expansion or decreased stem cell lineage extinction would be unrecognizable.
Other FAP studies are consistent with enhanced stem cell survival. Somatic mutation frequencies measured by visible losses of O-acetyltransferase crypt activity are increased threefold in nonneoplastic FAP colons.36 Enhanced stem cell survival would increase mutation frequencies because more stem cells would be at risk, or such neutral mutations would persist for greater amounts of time. A quantitative study of a labeling index shift after bromodeoxyuridine injection was also consistent with a numerical stem cell increase in FAP crypts.37
Pathways to Cancer: APC and Clonal Evolution
Our pretumor progression model may explain why certain pathways to cancer are more common than others. In non-FAP colons, APC alleles are wild-type and niche stem cell survival is random. Mutations could occur anywhere within the APC locus, but mutations that do not enhance stem cell survival will be frequently lost during normal stem cell turnover. An APC mutation near its MCR appears to enhance stem cell survival, perhaps by increasing niche adhesion or its sensitivity to WNT signals. Although this enhanced stem cell survival was inferred at equilibrium in FAP crypts when all stem cells harbor the same mutation, it is easy to envision that the survival advantage acquired somatically would allow for a rapid selective sweep of a wild-type niche. A selective sweep would increase the number of APC mutant cells by division rather than mutation and essentially convert a wild-type crypt into a FAP crypt. Therefore, APC mutations around its MCR would be fixed more frequently and appear more frequently in sporadic cancers.
Despite enhanced stem cell survival, FAP crypts were still defined by niches, suggesting immortal stem cells are incompatible with normal colon morphology or pretumor progression. Another APC mutation could confer additional selective advantages and displace other less fit niche stem cells. In this way, niches could continuously select for second or even third APC mutations2,38 during pretumor progression. Niche selection could also continue during tumor progression because adenomas appear to maintain a crypt hierarchy, with adenoma stem cells and more differentiated adenoma cells.39,40
FAP niches not only allow for additional selective mutations, but also facilitate the accumulation of initially neutral mutations by slowing stem cell clonal evolution. Intervals before extinction are longer in FAP colons, with niche succession occurring on average approximately every 30 years versus approximately every 8.2 years in non-FAP crypts (compare Figure 5B
with 5A
in Calabrese et al16
). Therefore, initially neutral mutations will persist longer in FAP crypts, increasing the probability of acquiring other mutations that eventually and collectively confer a tumor phenotype. This effect (a stem cell acquiring other mutations before fixation) is similar to the stochastic tunneling progression shortcut described by Nowak and colleagues.41
APC mutations appear to be common in cancers because they confer both niche selection and slow down subsequent clonal evolution, a combination predicted to be among the fastest pathways to cancer if most pretumor mutations are initially neutral.16
FAP patient E without enhanced stem cell survival illustrates the potential importance of stem cell persistence and subsequent crypt diversity to progression. She had few polyps (
150) and became symptomatic from intestinal blood loss relatively late in life (at 41 years of age), suggesting delayed development of her polyposis.
FAP cancers appear clinically earlier than expected if germline APC mutations merely reduce total numbers of oncogenic mutations by one relative to sporadic cancers.26,27
Our analysis and others26,27,42,43
illustrate that small changes in survival during early progression can influence subsequent cancer rates. Our model demonstrates how a single mutation can increase subsequent progression rates by more than a single step, without changing visible phenotype, mutation, or division rates (Figure 6)
. AFAP may be associated with inherited APC mutations that reduce the total number of somatic oncogenic mutations required for cancer, but do not enhance stem cell survival (like patients E and F), resulting in cancers 10 to 15 years later than FAP.44
Many factors likely influence progression rates or stem cell survival because identical germline APC mutations may yield different FAP phenotypes.45
Summary
The roles of APC mutations may differ during progression. Specific heterozygous APC mutations appear to promote pretumor progression by combining "gatekeeper" and "caretaker" niche defects (Figure 7)
. Higher FAP crypt diversity is similar to the increased mutation burden expected after caretaker mutations,46
except diversity results from slower clonal evolution rather than increased mutation rates. In FAP, this "caretaker" defect would start from birth, conserving initially neutral mutations in normal colon until tumors appear decades later. A sporadic APC mutation could initiate a limited "gatekeeper" defect allowing a visibly occult selective sweep of its niche, followed by a "caretaker" defect comparable to FAP crypts (Figure 7)
. Mutation of the second APC allele may be a "gatekeeper defect" that causes a permanent imbalance of cell division over cell death, or neoplasia.1
|
Prospectus
A pretumor progression model proposes most oncogenic cancer mutations first occur in normal appearing colon.16
It is unlikely our model captures all relevant parameters, but it illustrates the type of data and analysis required to reconstruct events before tumorigenesis. Central to our model is the clonal evolution of stem cell populations, which is inherent to niches. Multiple niche stem cells allow for selection, limited clonal expansions, and progression without elevated mutation rates or tumorigenesis. Evidence for our model is scant compared to the adenoma-cancer sequence because in the absence of visual progression clues, pretumor progression must be inferred. Literally none of its changes would ever be seen (Figure 1)
. Nevertheless, we demonstrate theoretical feasibility16
and provide experimental data that support major features of pretumor progression. Ages at DNA mismatch repair loss suggest most oncogenic cancer mutations accumulate before tumorigenesis or instability.47
Enhanced stem cell survival associated with certain heterozygous APC mutations is consistent with selection and niche clonal evolution during pretumor progression. In the absence of tumorigenesis or elevated mutation rates, subtle early changes in stem cell niche dynamics acting over many years may favor progression because APC mutations are found in most colorectal cancers. Progression is likely to be heterogeneous and a pretumor progression model may best fit cancers that appear shortly after negative clinical examinations. Pretumor progression may be important for a variety of cancers because most mammalian tissues appear to be maintained by stem cell niches15
and common tumors visibly appear late in life. Cancers and their mutations may reflect a lifetime of competition, first between stem cells during pretumor progression, and later between tumor cells during tumor progression.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by the National Institutes of Health (grants DK61140 to D.S., GM58897 and GM67243 to S.T.) and the National Science Foundation (grant DMS-0102008 to P.C.).
Accepted for publication December 29, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. M. Boman and E. Huang Human Colon Cancer Stem Cells: A New Paradigm in Gastrointestinal Oncology J. Clin. Oncol., June 10, 2008; 26(17): 2828 - 2838. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Boman, J. Z. Fields, K. L. Cavanaugh, A. Guetter, and O. A. Runquist How Dysregulated Colonic Crypt Dynamics Cause Stem Cell Overpopulation and Initiate Colon Cancer Cancer Res., May 1, 2008; 68(9): 3304 - 3313. [Abstract] [Full Text] [PDF] |
||||
![]() |
W W J de Leng, M Jansen, J J Keller, M de Gijsel, A N A Milne, F H M Morsink, M A J Weterman, C A Iacobuzio-Donahue, H C Clevers, F M Giardiello, et al. Peutz Jeghers syndrome polyps are polyclonal with expanded progenitor cell compartment Gut, October 1, 2007; 56(10): 1475 - 1476. [Full Text] [PDF] |
||||
![]() |
F. F. Costa, K. Le Blanc, and B. Brodin Concise Review: Cancer/Testis Antigens, Stem Cells, and Cancer Stem Cells, March 1, 2007; 25(3): 707 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Woodward, M. S. Chen, F. Behbod, M. P. Alfaro, T. A. Buchholz, and J. M. Rosen WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells PNAS, January 9, 2007; 104(2): 618 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. McCartney, M. H. Price, R. L. Webb, M. A. Hayden, L. M. Holot, M. Zhou, A. Bejsovec, and M. Peifer Testing hypotheses for the functions of APC family proteins using null and truncation alleles in Drosophila Development, June 15, 2006; 133(12): 2407 - 2418. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Roy, Y. L. Kim, Y. Liu, R. K. Wali, M. J. Goldberg, V. Turzhitsky, J. Horwitz, and V. Backman Risk Stratification of Colon Carcinogenesis through Enhanced Backscattering Spectroscopy Analysis of the Uninvolved Colonic Mucosa Clin. Cancer Res., February 1, 2006; 12(3): 961 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, X. Zhong, S. Zheng, Z. Ge, Q. Du, and S. Zhang Transformation of immortalized colorectal crypt cells by microcystin involving constitutive activation of Akt and MAPK cascade Carcinogenesis, July 1, 2005; 26(7): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Calabrese, S. Tavare, and D. Shibata Pretumor Progression: Clonal Evolution of Human Stem Cell Populations Am. J. Pathol., April 1, 2004; 164(4): 1337 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Calabrese, J.-L. Tsao, Y. Yatabe, R. Salovaara, J.-P. Mecklin, H. J. Jarvinen, L. A. Aaltonen, S. Tavare, and D. Shibata Colorectal Pretumor Progression Before and After Loss of DNA Mismatch Repair Am. J. Pathol., April 1, 2004; 164(4): 1447 - 1453. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |